Last Posted: Jul 26, 2018
- Should we screen hereditary thrombophilia testing in patients with provoked/unprovoked venous thromboembolism?
Ulas Turgay et al. International journal of cardiology 2018 Jul - Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial.
Syn Nicholas L et al. BMC medicine 2018 Jul 16(1) 104 - Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer.
Muñoz Martín Andrés J et al. British journal of cancer 2018 Mar - Type of Combined Contraceptives, Factor V Leiden Mutation and Risk of Venous Thromboembolism.
Hugon-Rodin Justine et al. Thrombosis and haemostasis 2018 Apr - Are you at risk for clots?
A family history of blood clots can increase a person?s risk. - Advances in predicting venous thromboembolism risk in children.
Rühle Frank et al. British journal of haematology 2017 Dec - Hereditary Thrombophilia in Trauma Patients with Venous Thromboembolism: Is Routine Screening Necessary?
Cannon Kathleen A et al. The journal of trauma and acute care surgery 2017 Nov - Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial.
Gage Brian F et al. JAMA 2017 Sep 318(12) 1115-1124 - Thrombophilia Testing and Venous Thrombosis
JM Connors, NEJM, Sep 2017 - Management of hereditary antithrombin deficiency in pregnancy.
James Andra H et al. Thrombosis research 2017 May 15741-45
.png)
No hay comentarios:
Publicar un comentario